Patent Description:
Polyesters produced from ester bond-forming monomers, represented by polylactic acid, polyglycolic acid, polycaprolactone, or copolymers thereof, are attracting attention as biodegradable or bioabsorbable polymers and are used in various fields including medical materials such as sutures, and sustained-release materials such as pharmaceuticals, agricultural chemicals, and fertilizers. Furthermore, they are also expected to serve as a packaging material such as a container and a film as a biodegradable general-purpose plastic.

However, in general, biodegradable polyesters and bioabsorbable polyesters produced from ester bond-forming monomers are fragile. Therefore, attempts have been made to develop various copolymers for the purpose of improving mechanical properties and obtaining a biodegradable polymer having practical strength and moldability.

For example, as a biodegradable/bioabsorbable polymer having a low Young's modulus and a high tensile strength, there has been proposed a polyester copolymer containing residues of two types of ester bond-forming monomers ("monomer A" and "monomer B") as main structural units, in which an R value represented by the following formula is <NUM> or more and <NUM> or less and in which a degree of crystallization of at least one of monomer A residues and monomer B residues is less than <NUM>% (see, for example, Patent Document <NUM>).

Attempts have also been made to improve mechanical properties by mixing biodegradable polymers. For example, as a composition having improved strength, flexibility, elongation percentage, tenacity, and the like, a biodegradable polymer blend (see, for example, Patent Document <NUM>) containing at least one hard synthetic biodegradable polymer and at least one soft synthetic biodegradable polymer, having a higher strength and/or elongation than those of the hard or soft biodegradable polymer by themselves, and suitable for formation into at least one of a sheet or a film, a resin composition (see, for example, Patent Document <NUM>) containing polylactic acid, an L-lactide/ε-caprolactone copolymer, and a filler, and the like have been proposed. Patent document <NUM> discloses a resin composition containing (A) polylactic acid, (B) a resin selected from thermoplastic resins and (C) a block copolymer. A polyester copolymer having two types of ester bond-forming monomer residues as main structural units, and satisfying an R value and a crystallization rate (Patent document <NUM>).

In general, it is known that polylactic acid and polyglycolic acid have high crystallinity and have high Young's moduli and are hard. However, molded bodies of these polymers have poor softness and are inferior in bio-followability required for medical materials. In addition, it has been reported that its hardness causes damage to surrounding tissues or protrusion accidents when embedded in the body.

Therefore, it has been studied to impart softness by copolymerizing polycaprolactone with these polymers. A multi-gradient polymer disclosed in Patent Document <NUM> has a low Young's modulus and a high tensile strength and is thus easy to mold and difficult to break, and the polymer is suitable for a filler and a covering material. On the other hand, in applications such as a support and a fixing base material, in addition to these characteristics, ease of elastic deformation, that is, excellent flexibility, is required.

In addition, the resin composition described in Patent Documents <NUM> and <NUM> has a high Young's modulus, and a material having a low Young's modulus is required from the viewpoint of formability.

In view of the above problems, an object of the present invention is to provide a polymer composition having a low Young's modulus, a high tensile strength, and excellent flexibility.

The present invention is a polymer composition containing polylactic acid, and a dilactide/ε-caprolactone copolymer, in which a content of the polylactic acid relative to a total of <NUM> mass% of the polylactic acid and the dilactide/ε-caprolactone copolymer is <NUM> to <NUM> mass%, and in which the dilactide/ε-caprolactone copolymer satisfies (<NUM>) and (<NUM>) below:.

The present invention also provides a molded body made of the polymer composition of the present invention.

In addition, the present invention is a nerve regeneration inducing tube at least partially including the polymer composition of the present invention.

According to the present invention, a polymer composition having a low Young's modulus, a high tensile strength, and excellent flexibility can be obtained.

Polylactic acid in the polymer composition of the present invention is a polymer obtained by polymerizing lactic acid by ester bonds. The polylactic acid may be a copolymer containing a component other than lactic acid, but the molar fraction of lactic acid in the polylactic acid is preferably <NUM>% or more, more preferably <NUM>% or more, still more preferably <NUM>%, so as to increase the crystallinity of lactic acid. There are two types of lactic acid, L-lactic acid and D-lactic acid, but a homopolymer of L-lactic acid is preferable from the viewpoint of biocompatibility in medical applications.

The weight average molecular weight of the polylactic acid is preferably <NUM>,<NUM> or more from the viewpoint of making the molecular chain difficult to unravel and further improving flexibility. Furthermore, <NUM>,<NUM> or more is more preferable from the viewpoint of further improving the tensile strength. On the other hand, the weight average molecular weight of the polylactic acid is preferably <NUM>,<NUM> or less so that the Young's modulus of the polymer composition will not increase due to excessive crystallization. Here, the weight average molecular weight of the polylactic acid refers to a value in terms of polystyrene and can be measured by gel permeation chromatography (GP).

The polylactic acid can be obtained by polymerizing or copolymerizing lactic acids such as L-lactic acid and D-lactic acid. The polylactic acid can be synthesized, for example, by ring-opening polymerization of dilactide. The following describes an example of a method for synthesizing polylactic acid using L-dilactide.

First, L-dilactide and a co-initiator are collected in a separable flask. Examples of the co-initiator include lauryl alcohol.

Next, a catalyst is added under a nitrogen atmosphere, and the mixture is stirred while being heated so that the raw material is uniformly dissolved or melted. Examples of the catalyst include tin (II) octylate. The heating temperature is preferably from the viewpoint of uniformly dissolving the raw materials and, on the other hand, preferably <NUM> or lower from the viewpoint of suppressing volatilization of the raw materials. The stirring speed is preferably <NUM> rpm or more and <NUM> rpm or less. The heating time is preferably <NUM> minutes or more and <NUM> minutes or less.

The mixture is further heated and allowed to stand for <NUM> hour, the temperature is then lowered, and the mixture is further allowed to stand. The heating temperature at this time is preferably <NUM> or more and <NUM> or less. The standing time is preferably <NUM> hours or less from the viewpoint of suppressing excessive polymerization. The temperature when the temperature is lowered is preferably <NUM> or higher from the viewpoint of allowing the reaction to proceed and, on the other hand, is preferably <NUM> or lower from the viewpoint of suppressing volatilization of L-dilactide. The standing time is preferably <NUM> hours or less.

Thereafter, the inside of the flask is brought into a reduced pressure state while the temperature is maintained, and unreacted L-dilactide is removed. Finally, the reaction mixture is dissolved in chloroform or the like and added dropwise to methanol being stirred to precipitate polylactic acid. The stirring speed of methanol is preferably <NUM> rpm or more and <NUM> rpm or less. It is preferable to perform drying in order to remove the solvent in the obtained polylactic acid. The drying time is preferably <NUM> hours or more.

A dilactide/ε-caprolactone copolymer in the polymer composition of the present invention satisfies (<NUM>) and (<NUM>) below.

The R value can be determined by quantifying the ratio of combinations of two adjacent monomers (A-A, B-B, A-B, and B-A) by nuclear magnetic resonance (NMR) measurement. Specifically, the dilactide/ε-caprolactone copolymer is dissolved in deuterated chloroform, and the ratio of the dilactide residues to the ε-caprolactone residues in the dilactide/ε-caprolactone copolymer is calculated by <NUM>H-NMR analysis. In addition, regarding the methine group of dilactide (around <NUM> ppm), the α-methylene group of ε-caprolactone (around <NUM> ppm), and the ε-methylene group (around <NUM> ppm), adjacent monomer residues are separated by a signal derived from lactide or ε-caprolactone by <NUM>H homo-spin decoupling, and each peak area is quantified. From each area ratio, [AB] of Formula <NUM> is calculated to calculate the R value. Here, [AB] is the molar fraction (%) of a structure in which the dilactide residue and the ε-caprolactone residue are adjacent to each other and specifically is the ratio of the number of A-B and B-A to the total number of A-A, A-B, B-A, and B-B.

The R value is used as an index indicating the randomness of the sequence of monomer residues in the dilactide/ε-caprolactone copolymer. For example, in a random copolymer having a completely random monomer sequence, the R value is <NUM>. When the R value is <NUM> or more, crystallinity is low, and softness is excellent. The R value is preferably <NUM> or more. On the other hand, when the R value is <NUM> or less, adhesiveness can be suppressed. The R value is preferably <NUM> or less.

(<NUM>) At least one of the dilactide residue and the ε-caprolactone residue has a degree of crystallization of less than <NUM>%.

When the degree of crystallization is less than <NUM>%, a polyester copolymer suitable for medical materials and elastomer applications can be obtained by reducing the Young's modulus to provide softness. In the present invention, the degree of crystallization of the dilactide residues is preferably less than <NUM>%, more preferably <NUM>% or less.

The degree of crystallization of monomer residues as used herein is the ratio of the heat of fusion per unit mass of a certain type of monomer residues in the dilactide/ε-caprolactone copolymer to the product of the heat of fusion per unit mass of a homopolymer composed of only the monomer residues and the mass fraction of the monomer residues in the dilactide/ε-caprolactone copolymer. That is, the degree of crystallization of the dilactide residues is the ratio of the heat of fusion per unit mass of the dilactide residue residues in the dilactide/ε-caprolactone copolymer to the product of the heat of fusion per unit mass of a homopolymer composed only of dilactide and the mass fraction of the dilactide residue residues in the dilactide/ε-caprolactone copolymer. The degrees of crystallization of the dilactide residues and the ε-caprolactone residues each indicate a ratio of the dilactide residues or the ε-caprolactone residues having a crystal structure in the dilactide/ε-caprolactone copolymer. Here, the degree of crystallization can be measured by DSC using a differential scanning calorimeter.

The dilactide/ε-caprolactone copolymer may be linear or branched.

The weight average molecular weight of the dilactide/ε-caprolactone copolymer is preferably <NUM>,<NUM> or more, more preferably <NUM>,<NUM> or more, from the viewpoint of further reducing the Young's modulus of the polymer composition and further improving the tensile strength. On the other hand, the weight average molecular weight of the dilactide/ε-caprolactone copolymer is preferably <NUM>,<NUM> or less from the viewpoint of the viscosity and solubility of the polymer composition described later. Here, the weight average molecular weight of the dilactide/ε-caprolactone copolymer refers to a value in terms of polystyrene and can be measured by gel permeation chromatography (GPC).

In the present invention, the dilactide/ε-caprolactone copolymer preferably has a gradient structure in which dilactide residues and ε-caprolactone residues form a composition gradient in the skeleton.

The gradient structure having a composition gradient in the skeleton refers to a structure in which the composition of monomer residues continuously changes from the polymerization initiation end to the polymerization termination end along the molecular chain.

Schematically, for example, the residue A and the residue B are arranged like
AAAAABAAABAABBABABBBBABBBB.

Since the dilactide/ε-caprolactone copolymer has a gradient structure in which the dilactide residues and the ε-caprolactone residues form a composition gradient in the skeleton, the crystallinity can be reduced, and softness can be provided, as compared with the case of a block copolymer structure.

The randomness of the distribution of the monomer residues constituting the dilactide/ε-caprolactone copolymer varies depending on the reactivity of the monomers during polymerization. That is, when one of the monomers of dilactide and caprolactone is bonded to the same type of monomer and the other type of monomer with the same probability during polymerization, a random copolymer in which monomer residues are completely randomly distributed is obtained. However, when one monomer tends to be easily bonded to a certain monomer, a gradient copolymer having a biased distribution of monomer residues is obtained.

Here, the reactivity is greatly different between dilactide and ε-caprolactone as described in the literature (<NPL>), and dilactide has a higher initial polymerization rate than ε-caprolactone. An initial polymerization rate VA of dilactide is <NUM>%/h in terms of reaction rate (%), and an initial polymerization rate VB of ε-caprolactone is <NUM>%/h. When dilactide and ε-caprolactone are copolymerized, dilactide is easily bonded to dilactide. Therefore, a gradient structure in which the proportion of the dilactide units gradually decreases from the polymerization initiation end to the polymerization termination end is formed.

That is, according to a copolymerization method in which monomers of dilactide and ε-caprolactone are mixed and allowed to react, in general, the dilactide/ε-caprolactone copolymer easily forms a gradient structure over the entire skeleton of the polymer.

Furthermore, in the present invention, the dilactide/ε-caprolactone copolymer has a gradient structure in units of macromers and preferably has a structure in which two or more macromer units are linked.

Here, the "macromer" means a high molecular weight compound having a polymerizable functional group, and in a polymer, the macromer unit constitutes a part of the skeleton of the polymer. In a structure in which two or more macromer units having a gradient structure are linked, an arrangement such as
(AAABAABBABBB)·(AAABAABBABBB)
is formed.

Hereinafter, a macromer having a gradient structure is also referred to as a "gradient macromer", and a unit of the gradient macromer in the polymer is also referred to as a "gradient macromer unit".

With the structure in which two or more gradient macromer units are linked, it is possible to effectively obtain a dilactide/ε-caprolactone copolymer with controlled randomness as in (<NUM>) described above, and it is possible to obtain a dilactide/ε-caprolactone copolymer with effectively reduced crystallinity as in (<NUM>) described above, even when the degree of polymerization is increased. Therefore, according to such a preferred aspect, a polymer composition having a low Young's modulus and a high tensile strength can be effectively obtained.

The number of macromer units in the structure in which macromer units are linked is preferably <NUM> or more, more preferably <NUM> or more, from the viewpoint of further enhancing the tensile strength. On the other hand, from the viewpoint of moderately reducing the viscosity and improving the handleability, the number of linked macromer units is preferably <NUM> or less.

A structure in which two or more gradient macromer units are linked is hereinafter also referred to as a "multi-gradient structure", and a copolymer having a multi-gradient structure is also referred to as a "multi-gradient copolymer".

In the present invention, the maximum point stress when the dilactide/ε-caprolactone copolymer is formed into a film is preferably <NUM> MPa or more and <NUM> MPa or less, which is about equal to the maximum point stress of a biological tissue. In addition, the Young's modulus of the dilactide/ε-caprolactone copolymer is preferably <NUM> MPa or more and <NUM> MPa or less, which is about equal to the Young's modulus of a biological tissue.

Here, the maximum point stress and Young's modulus when the dilactide/ε-caprolactone copolymer is formed into a film can be measured in accordance with a method defined in JIS K <NUM> (<NUM>). Specifically, a solution obtained by drying a copolymer of dilactide/ε-caprolactone under reduced pressure and dissolving the product in chloroform so as to achieve a concentration of <NUM> mass% is transferred onto a petri dish made of "Teflon" (registered trademark) and dried at normal pressure and room temperature for one day and night. A polymer film having a thickness of <NUM> obtained by drying the product under reduced pressure is cut into a strip shape (<NUM> × <NUM>), and the maximum point stress and the Young's modulus are measured by performing a tensile test under the following conditions using a small desktop tester EZ-LX (manufactured by Shimadzu Corporation):.

The maximum point stress and the Young's modulus of the copolymer of dilactide/ε-caprolactone can be determined by performing measurement three times each and calculating the number average value.

Setting the maximum point stress and Young's modulus of the dilactide/s-caprolactone copolymer within the above ranges can be effectively achieved by forming a structure in which two or more gradient macromer units are linked by a production method including a multimerization step described later.

As an example, a production method of the dilactide/ε-caprolactone copolymer includes:.

In the macromer synthesis step, dilactide and ε-caprolactone are blended such that the sum of the dilactide residues and the ε-caprolactone residues is <NUM> mol% or more of the whole residues and such that the dilactide residues and the ε-caprolactone residues are each <NUM> mol% or more of the whole residues at the completion of polymerization in theory, and polymerization is performed. As a result, a dilactide/ε-caprolactone copolymer containing dilactide residues and ε-caprolactone residues as main structural units is obtained, but in the present production method, since the multimerization step described later is further performed, the dilactide/ε-caprolactone copolymer obtained in this step is referred to as a "macromer" in the present specification.

In this step, a macromer having a gradient structure in which the dilactide residues and the ε-caprolactone residues form a composition gradient in the skeleton is obtained because of the difference in initial polymerization rates between dilactide and ε-caprolactone.

In the macromer synthesis step, in order to realize such a gradient structure, it is desirable to synthesize the macromer by a polymerization reaction occurring in one direction from the initiation end. Preferable examples of such a synthesis reaction include ring-opening polymerization and living polymerization.

An example of the method for synthesizing a lactide/caprolactone macromer will be described more specifically. First, dilactide, ε-caprolactone, and a catalyst are placed in a reaction vessel equipped with a stirrer and stirred while being heated under a nitrogen stream. In order to remove moisture in the reaction vessel, it is preferable to perform heating and stirring in the reaction vessel under reduced pressure.

As the stirrer, a stirrer equipped with a propeller-type stirring blade is preferable, and the rotation speed of the stirring blade is preferably <NUM> rpm or more and <NUM> rpm or less.

The heating temperature in the polymerization reaction is preferably <NUM> or higher and <NUM> or lower. The reaction time of the polymerization reaction is preferably <NUM> hours or more, more preferably <NUM> hours or more, still more preferably <NUM> hours or more, from the viewpoint of increasing the degree of polymerization. On the other hand, the reaction time of the polymerization reaction is preferably <NUM> hours or less from the viewpoint of further improving productivity.

It is preferable that dilactide and ε-caprolactone are used after being purified in advance in order to remove impurities.

Examples of the catalyst include tin octylate, antimony trifluoride, zinc powder, dibutyltin oxide, and tin oxalate. Examples of the method for adding the catalyst to the reaction system include a method in which the catalyst is added such that the catalyst is dispersed in the raw materials at the time of charging the raw materials and a method in which the catalyst is added in a dispersed state in a medium at the time of starting the pressure reduction or immediately before starting the heating in the above-described method. The amount of the catalyst used is preferably <NUM> parts by mass or more, more preferably <NUM> parts by mass or more, in terms of metal atoms with respect to a total of <NUM> parts by mass of dilactide and ε-caprolactone from the viewpoint of shortening the reaction time and further improving the productivity. On the other hand, the amount of the catalyst used is preferably <NUM> parts by mass or less in terms of metal atoms with respect to the total amount of dilactide and ε-caprolactone from the viewpoint of further reducing the amount of metal remaining in the dilactide/ε-caprolactone copolymer.

When water is used as a co-initiator, it is preferable to perform a cocatalyst reaction at around <NUM> prior to the polymerization reaction.

The macromer obtained in this step preferably has an R value similar to that of the dilactide/ε-caprolactone copolymer described in the above (<NUM>), that is, an R value represented by the following formula of <NUM> or more and <NUM> or less, more preferably <NUM> or more and <NUM> or less, <MAT>.

in order to facilitate the production of the dilactide/ε-caprolactone copolymer that finally satisfies the R value shown in the above (<NUM>).

Similarly, the macromer obtained in this step has the degree of crystallization of the monomer residues described in the above (<NUM>), that is, the degree of crystallization of at least one of the dilactide residues and the ε-caprolactone residues is preferably less than <NUM>%, more preferably <NUM>% or less, still more preferably <NUM>% or less, and most preferably <NUM>% or less, in order to facilitate the production of the dilactide/ε-caprolactone copolymer finally having the degree of crystallization of the dilactide residues or the ε-caprolactone residues shown in the above (<NUM>).

The weight average molecular weight of the macromer synthesized in the macromer synthesis step is preferably <NUM>, <NUM> or more, more preferably <NUM>, <NUM> or more. In addition, in order to further reduce the crystallinity and further improve the softness, it is preferably <NUM>,<NUM> or less, more preferably <NUM>,<NUM> or less.

In the multimerization step, the macromers obtained in the macromer synthesis step are linked to each other, or dilactide and caprolactone are additionally added to the macromer solution obtained in the macromer synthesis step to perform multimerization. In this step, the macromers obtained in one macromer synthesis step may be linked to each other, or a plurality of macromers obtained in two or more macromer synthesis steps may be linked to each other. The term "multimerization" means that the dilactide residues and the caprolactone residues form a structure in which a plurality of molecular chains having a gradient structure having a composition gradient in the skeleton are repeated by any one of these methods.

The number of linked macromer units can be adjusted with the catalyst used in the multimerization step and the reaction time. When multimerization is performed by linking macromers, the number of macromer units can be determined by dividing the weight average molecular weight of the finally obtained dilactide/ε-caprolactone copolymer by the weight average molecular weight of the macromer.

The reaction temperature in the condensation reaction in the multimerization step is preferably <NUM> or higher from the viewpoint of efficiently promoting the condensation reaction. On the other hand, the reaction temperature of the condensation reaction is preferably <NUM> or lower from the viewpoint of suppressing volatilization of the solvent. The reaction time in the condensation reaction is preferably <NUM> hours or more from the viewpoint of setting the number of macromer units to be multimerized to the above-mentioned preferable range. On the other hand, the reaction time of the condensation reaction is preferably <NUM> hours or less from the viewpoint of narrowing the molecular weight distribution.

In the case of producing a linear dilactide/ε-caprolactone copolymer, for example, it can be synthesized by bonding similar gradient macromers to both ends of the gradient macromer one molecule at a time via the ends.

When the gradient macromer has a hydroxy group and a carboxy group at respective ends, the ends are condensed with a condensing agent to provide a multimerized dilactide/ε-caprolactone copolymer. Examples of the condensing agent include <NUM>,<NUM>-dimethylaminopyridinium p-toluenesulfonate, N,N'-dicyclohexylcarbodiimide, N,N'-diisopropylcarbodiimide, and N,N'-carbonyldiimidazole. Two or more of these compounds may be used.

In addition, when the polymerization reaction is living, that is, when the polymerization reaction can be continuously started from the end of the polymer, multimerization can be performed by repeating an operation of additionally adding dilactide and ε-caprolactone to the gradient macromer solution after the completion of the polymerization reaction.

Alternatively, the gradient macromers may be multimerized via a linker as long as the dynamic characteristics of the polymer are not affected. In particular, when a linker containing a plurality of carboxy groups and/or a plurality of hydroxy groups, such as <NUM>,<NUM>-bis (hydroxymethyl)propionic acid, is used, a branched polyester copolymer in which the linker serves as a branch point can be synthesized.

The dilactide/ε-caprolactone copolymer obtained by the production method as described above is a copolymer having a structure in which two or more macromer units each including didilactide residues and caprolactone residues having a composition gradient in the skeleton of are linked, and this is a preferred aspect of the dilactide/ε-caprolactone copolymer of the present invention.

The polymer composition of the present invention contains the above-described polylactic acid and the dilactide/ε-caprolactone copolymer.

The dilactide/ε-caprolactone satisfying the above (<NUM>) and (<NUM>) has a low degree of crystallization, a reduced Young's modulus, and an improved tensile strength but is in a state in which the molecular chains are merely entangled with each other. Therefore, the dilactide/ε-caprolactone is first deformed so that the entanglement between the molecular chains is alleviated when the dilactide/ε-caprolactone is subjected to stress, an elastic force is hardly generated, and the dilactide/ε-caprolactone has low flexibility at the initial stage of elongation. On the other hand, it is considered that polylactic acid has high crystallinity and forms a crystal structure with the dilactide residue in the dilactide/ε-caprolactone copolymer. It is considered that, due to such a crystal structure, a crosslinking point is formed between molecular chains of the dilactide/ε-caprolactone copolymer, an elastic force like rubber is exerted when stress is applied, and flexibility can be improved.

The polymer composition of the present invention is required to contain <NUM> to <NUM> mass% of polylactic acid with respect to a total of <NUM> mass% of the polylactic acid and the dilactide/ε-caprolactone copolymer. When the content of the polylactic acid is <NUM> mass% or more, more preferably <NUM> mass% or more, crystal formation of the polylactic acid and the dilactide residues is made sufficient, and flexibility can be improved. On the other hand, by setting the content of the polylactic acid to <NUM> mass% or less, more preferably <NUM> mass% or less, excessive crystallization of the polylactic acid and dilactide can be suppressed, and an increase in Young's modulus and a decrease in tensile strength can be prevented.

The maximum point stress when the polymer composition of the present invention is formed into a film is preferably <NUM> MPa or more and <NUM> MPa or less, which is about equal to the maximum point stress of a biological tissue. In addition, the Young's modulus is preferably <NUM> MPa or more and <NUM> MPa or less, which is about equal to the Young's modulus of a biological tissue.

The maximum point stress and Young's modulus when the polymer composition is formed into a film can be measured in accordance with a method defined in JIS K <NUM> (<NUM>), and the details are similar to those in the case of the dilactide/ε-caprolactone copolymer.

The polymer composition of the present invention can be obtained, for example, by stirring the above-described polylactic acid and dilactide/ε-caprolactone copolymer in a molten state or a solution state. From the viewpoint of suppressing thermal decomposition, stirring is preferably performed in a solution state. It is more preferable to put the polymers constituting the polymer composition together in the same solvent, dissolve the polymers with stirring, and then volatilize and remove the solvent.

The polymer composition of the present invention is excellent in flexibility and can therefore be used for a molded body for use involving frequent deformation. In particular, even when the molded body is transplanted into a body as a medical molded body, the molded body has softness to follow the deformation of the body, exhibits resistance to deformation of a certain level or more, and can also serve as a support. In particular, application to a nerve regeneration inducing tube that requires such a function is preferable.

The present invention will be described below with reference to specific examples, but the present invention should not be construed as limited to these examples, and all technical ideas that a person skilled in the art who has come across the concept of the present invention will think of and conceive as being implementable and specific aspects thereof should be understood as being included in the present invention.

A dilactide/ε-caprolactone copolymer or polylactic acid to be measured was dissolved in chloroform and allowed to pass through a <NUM> syringe filter (DISMIC-13HP; manufactured by ADVANTEC) to remove impurities and the like. Then, the weight average molecular weights of the dilactide/ε-caprolactone copolymer and the polylactic acid in terms of polystyrene were calculated on the basis of GPC measurement under the following conditions.

The dilactide/ε-caprolactone copolymer to be measured was collected in an aluminum pan, and the heat of fusion was calculated on the basis of DSC using a differential scanning calorimeter (EXTAR <NUM>; manufactured by Seiko Instruments Inc. ) under the following conditions. From the obtained value of the heat of fusion, the degree of crystallization was calculated by the following formula.

The dilactide/s-caprolactone copolymer to be measured was dissolved in deuterated chloroform, and the ratio of the dilactide residues to the caprolactone residues in the dilactide/ε-caprolactone copolymer was calculated by <NUM>H-NMR under the following conditions. In addition, the methine group of lactide (around <NUM> ppm), the α-methylene group of caprolactone (around <NUM> ppm), and the ε-methylene group (around <NUM> ppm) were separated on the basis of a signal derived from an adjacent monomer residue, lactide or caprolactone, by <NUM>H homo-spin decoupling, and each peak area was quantified. From each area ratio, [AB] of Formula <NUM> was calculated to calculate the R value. Here, [AB] is the molar fraction (%) of a structure in which the dilactide residue and the caprolactone residue are adjacent to each other and specifically is the ratio of the number of A-B and B-A to the total number of A-A, A-B, BA, and B-B.

A solution obtained by drying a dilactide/ε-caprolactone copolymer or a polymer composition solution obtained in each of examples and comparative examples under reduced pressure and dissolving the product in chloroform so as to achieve a concentration of <NUM> wt% was transferred onto a petri dish made of "Teflon" (registered trademark) and dried at normal pressure and room temperature for one day and night. The product was dried under reduced pressure to provide a polymer composition film.

The obtained film (thickness: about <NUM>) was cut into a strip shape (<NUM> × <NUM>), and a tensile test was conducted under the following conditions in accordance with JIS K <NUM> (<NUM>) using EZ-LX (manufactured by Shimadzu Corporation) to calculate the Young's modulus and the maximum point stress. The measurement conditions in JIS K <NUM> applied mutatis mutandis in the present invention are common to the <NUM> edition and the <NUM> edition.

In the extension-stress curve (<FIG>) obtained by performing a tensile test by the method described in the above (<NUM>) using the polymer composition solution or the polymer solution obtained in each of the examples and comparative examples, the stress until the elongation at which the maximum point stress was observed was approximated by a linear equation (Y = aX, where Y is stress, X is extension, and a is a constant), and a coefficient r<NUM> of determination was calculated from the average value obtained by tests repeated three times. Since flexibility is the ease of elastic deformation, it means that the closer the value of the coefficient r<NUM> of determination is to <NUM>, the easier the elastic deformation is, and a coefficient of determination of <NUM> or more is an indication of excellent flexibility.

As monomers, <NUM> of L-dilactide (manufactured by Corbion N. ) and <NUM> of ε-caprolactone (manufactured by Wako Pure Chemical Industries, Ltd. ) were collected in a separable flask. Under a nitrogen atmosphere, a solution in which <NUM> parts by mass (in terms of tin) of tin (II) octylate (manufactured by Wako Pure Chemical Industries, Ltd. ) as a catalyst with respect to a total of <NUM> parts by mass of dilactide and ε-caprolactone was dissolved in <NUM> of toluene (super dehydrated) (manufactured by Wako Pure Chemical Industries, Ltd. ) and <NUM> of hydroxypivalic acid (manufactured by Tokyo Chemical Industry Co. ) as a co-initiator were added, and the mixture was stirred at a stirring speed of <NUM> rpm for <NUM> hours while being heated to <NUM> and subjected to a copolymerization reaction to provide a macromer solution.

To the resulting macromer solution were added <NUM> of <NUM>,<NUM>-dimethylaminopyridinium p-toluenesulfonate (synthetic product) as a catalyst and <NUM> of <NUM>,<NUM>-dimethylaminopyridine (manufactured by Wako Pure Chemical Industries, Ltd. These were dissolved in <NUM> of dichloromethane (dehydrated) (manufactured by Wako Pure Chemical Industries, Ltd. ) under a nitrogen atmosphere, <NUM> of dicyclohexylcarbodiimide (manufactured by Sigma-Aldrich Co. ) was added as a condensing agent, and the mixture was stirred at <NUM> and a stirring speed of <NUM> rpm for <NUM> hours to perform condensation polymerization.

To the reaction mixture, <NUM> of acetic acid (manufactured by Wako Pure Chemical Industries, Ltd. ) and chloroform in such an amount that the concentration of a dilactide/ε-caprolactone copolymer would be <NUM> mass% were added, and the mixture was stirred at <NUM> and a stirring speed of <NUM> rpm for <NUM> hours. Thereafter, the reaction mixture was added dropwise to <NUM> of methanol with stirring at a stirring speed of <NUM> rpm to provide a precipitate. The obtained precipitate was dried for <NUM> hours to provide a dilactide/ε-caprolactone copolymer having a multi-gradient structure. The obtained dilactide/ε-caprolactone copolymer had a weight average molecular weight of <NUM>,<NUM>, a degree of polymerization of a macromonomer unit of <NUM>, a degree of crystallization of dilactide residues of <NUM>%, a degree of crystallization of ε-caprolactone residues of <NUM>%, a molar fraction of dilactide residues of <NUM>%, a molar fraction of ε-caprolactone residues of <NUM>%, a molar fraction of a structure in which a dilactide residue and an ε-caprolactone residue were adjacent to each other of <NUM>%, an R value of <NUM>, a Young's modulus of <NUM> MPa, and a maximum point stress of <NUM> MPa.

In a separable flask, <NUM> of L-lactide (PURASORB L; PURAC) and <NUM> of ε-caprolactone (manufactured by FUJIFILM Wako Pure Chemical Corporation) as monomers and <NUM> of octanol as an initiator were collected.

The mixture was placed in an argon atmosphere, <NUM> of tin(II) octylate (manufactured by FUJIFILM Wako Pure Chemical Corporation) that was a catalyst dissolved in <NUM> of toluene (super dehydrated) (manufactured by FUJIFILM Wako Pure Chemical Corporation) was added thereto, and the mixture was allowed to react at <NUM> and a stirring speed of <NUM> rpm for <NUM> hours to provide a crude polymer.

The obtained crude polymer was dissolved in <NUM> of chloroform and added dropwise to <NUM>,<NUM> of hexane being stirred to provide a precipitate. The precipitate was dried under reduced pressure at <NUM> for <NUM> hours to provide a dilactide/ε-caprolactone copolymer having a gradient structure. The obtained dilactide/ε-caprolactone copolymer had a weight average molecular weight of <NUM>,<NUM>, a degree of crystallization of dilactide residues of <NUM>%, a degree of crystallization of ε-caprolactone residues of <NUM>%, a molar fraction of dilactide residues of <NUM>%, a molar fraction of ε-caprolactone residues of <NUM>%, a molar fraction of a structure in which a dilactide residue and an ε-caprolactone residue were adjacent to each other of <NUM>%, an R value of <NUM>, a Young's modulus of <NUM> MPa, and a maximum point stress of <NUM> MPa.

In <NUM> of chloroform, <NUM> of a mixture obtained by mixing the dilactide/ε-caprolactone copolymer obtained in Synthesis Example <NUM> and poly-L-lactic acid (manufactured by Corbion N. ) (weight average molecular weight: <NUM>,<NUM>) so that the mass ratio was dilactide/ε-caprolactone copolymer : polylactic acid = <NUM> : <NUM> was dissolved to prepare a polymer composition solution. The results evaluated by the above-described method are shown in Table <NUM>, and the extension-stress curve is shown in <FIG>.

In <NUM> of chloroform, <NUM> of the dilactide/ε-caprolactone copolymer obtained in Synthesis Example <NUM> was dissolved to prepare a polymer solution. The results evaluated by the above-described method are shown in Table <NUM>, and the extension-stress curve is shown in <FIG>.

A polymer composition solution was prepared in a similar manner to that in Example <NUM> except that the mass ratio of the dilactide/ε-caprolactone copolymer and the polylactic acid was changed to dilactide/ε-caprolactone copolymer : polylactic acid = <NUM> : <NUM>. The results evaluated by the above-described method are shown in Table <NUM>, and the extension-stress curve is shown in <FIG>.

In <NUM> of chloroform, <NUM> of poly-L-lactic acid (manufactured by Corbion N. ) was dissolved to prepare a polymer solution. The results evaluated by the above-described method are shown in Table <NUM>, and the extension-stress curve is shown in <FIG>.

A polymer composition solution was prepared in a similar manner to that in Example <NUM> except that the dilactide/ε-caprolactone copolymer was changed to that obtained in Synthesis Example <NUM>. The results evaluated by the above-described method are shown in Table <NUM>, and the extension-stress curve is shown in <FIG>.

A polymer composition solution was prepared in a similar manner to that in Example <NUM> except that the ratio of the dilactide/ε-caprolactone copolymer and the polylactic acid was changed to dilactide/ε-caprolactone copolymer : polylactic acid = <NUM> : <NUM>. The results evaluated by the above-described method are shown in Table <NUM>, and the extension-stress curve is shown in <FIG>.

Claim 1:
A polymer composition comprising:
polylactic acid; and
a dilactide/ε-caprolactone copolymer,
wherein a content of the polylactic acid relative to a total of <NUM> mass% of the polylactic acid and the dilactide/ε-caprolactone copolymer is <NUM> to <NUM> mass%, and
the dilactide/ε-caprolactone copolymer satisfies (<NUM>) and (<NUM>) below:
(<NUM>) an R value represented by a following formula is <NUM> or more and <NUM> or less: <MAT> where
[A] is a molar fraction (%) of a dilactide residue in the dilactide/ε-caprolactone copolymer,
[B] is a molar fraction (%) of an ε-caprolactone residue in the dilactide/ε-caprolactone copolymer, and
[AB] is a molar fraction (%) of a structure in which a dilactide residue and an ε-caprolactone residue are adjacent to each other (A-B and B-A) in the dilactide/ε-caprolactone copolymer, and
(<NUM>) at least one of the dilactide residue and the ε-caprolactone residue has a degree of crystallization of less than <NUM>% as measured according to the specification.